Nyxoah (NYXH) Revenue (2025 - 2026)

Nyxoah's quarterly Revenue came in at $7.5 million in Q1 2026, up 566.54% year-on-year from $1.1 million in Q1 2025, and up 566.54% quarter-over-quarter from $1.1 million in Q1 2025.

Nyxoah has reported Revenue for 2 years, with the latest figure at $7.5 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 2.77 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn 4.71 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 1.43 Bn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 844.90 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn 2.01 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 1.02 Bn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 1.04 Bn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn 2.70 Bn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 982.87 Mn
10 Nyxoah 1,248.49 1,248.49 4.26 Mn 7.46 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 7.46 Mn
Mar 31, 2025 1.12 Mn